Your search history is turned on.
Date: May 2, 2024 Jurisdictions: Alberta, British Columbia
FORM 51-102F3 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Akseera Biosciences Incorporated (the Company) 702 889 West Pender Street Vancouver, BC V6C 3B2 Item 2. Date of Material Change April 23, 2024. Item 3. News Release News release was filed on April 23, 2024, vi...
Date: April 23, 2024 Jurisdictions: Alberta, British Columbia
News Release AKSEERA BIOSCIENCES INCORPORATED Suite 702 - 889 West Pender Street, Vancouver, BC V6C 3B2 Tel: 604.683.3288 / Fax: 604.398.2890 NEWS RELEASE 2024 ANNUAL GENERAL MEETING Vancouver, BC April 23, 2024: Akseera Biosciences Incorporated (the Company) is pleased to announce that at the Companys annual general meetin...
Date: March 26, 2024 Jurisdictions: Alberta, British Columbia
AKSEERA BIOSCIENCES INCORPORATED (formerly 1132876 B.C. Ltd.) REQUEST FOR FINANCIAL STATEMENTS In accordance with National Instrument 51-102 Continuous Disclosure Obligations, shareholders may elect annually to receive a copy of Akseera Biosciences Incorporateds (the Company) annual financial statements and accompanying managements discussion an...
Proxy ANNUAL GENERAL MEETING OF SHAREHOLDERS OF AKSEERA BIOSCIENCES INCORPORATED (the "Company") TO BE HELD AT 702 889 WEST PENDER STREET, VANCOUVER, BRITISH COLUMBIA, V6C 3B2 ON TUESDAY, APRIL 23, 2024 AT 11:00 A.M. (PACIFIC TIME) The undersigned shareholder (Registered Shareholder) of the Company hereby appoints J...
AKSEERA BIOSCIENCES INCORPORATED 702 889 West Pender Street, Vancouver, BC V6C 3B2 Canada Telephone: 604.683.3288 INFORMATION CIRCULAR INFORMATION PROVIDED AS AT MARCH 19, 2024 FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 23, 2024. This information circular (Information Circular) is furnished in connection with t...
AKSEERA BIOSCIENCES INCORPORATED 702 889 West Pender Street, Vancouver, BC V6C 3B2 Canada Telephone: 604.683.3288 NOTICE OF ANNUAL GENERAL MEETING NOTICE IS HEREBY GIVEN that the annual general meeting (the Meeting) of the shareholders of Akseera Biosciences Incorporated (hereinafter called the Company) will be held at the o...
Date: February 29, 2024 Jurisdictions: Alberta, British Columbia
AKSEERA BIOSCIENCES INCORPORATED Interim Financial Statements For the six months ended December 31, 2023 (Expressed in Canadian Dollars) The Companys independent auditors have not performed a review of these consolidated financial statements in accordance with the standards established by the Chartered Professional Accountants of Canada for a revi...
Akseera Biosciences Incorporated MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE SIX MONTHS ENDED DECEMBER 31, 2023 1 February 28, 2024 This managements discussion and analysis (MD&A) focuses on events and activities that affected Akseera Biosciences Incorporated (the Company) during the six months e...
Akseera Biosciences Incorporated. FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, John Brydle, Chief Financial Officer for Akseera Biosciences Incorporated., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A, (together the Interim Filin...
CERTIFICATION OF ANNUAL FILINGS Akseera Biosciences Incorporated. FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, John Brydle, Chief Executive Officer for Akseera Biosciences Incorporated., certify the following: 1. Review: I have reviewed the interim financial report and interim ...